Results 141 to 150 of about 1,266,783 (261)
Extracellular vesicle (EV) lipidomic profiling of plasma and ascites from patients with high‐grade serous ovarian cancer and of ovarian cancer cell lines reveals enrichment of triglycerides (TGs), diacylglycerols (DGs), phosphatidylcholine (PCs), sphingomyelins (SMs), reflecting tumor metabolic reprogramming.
Shikha Rani +9 more
wiley +1 more source
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira +7 more
wiley +1 more source
HCAR2 the rescue: sensing heme, steering inflammation
Yunfeng Liu, Karina Yazdanbakhsh
doaj +1 more source
TA-TMA as a clinical model for precision complement therapeutics in stem cell transplantation. [PDF]
Jodele S.
europepmc +1 more source
Loss of NAPRT promotes lung tumor initiation and growth through a noncanonical mechanism, independent of its role in NAD+ biosynthesis. Mechanistically, NAPRT depletion activates the mTORC2‐driven AKT/β‐catenin signaling axis to enhance clonogenic and invasive phenotypes. Furthermore, lung‐specific Naprt deletion significantly increases tumor burden in
Myung Joon Oh +11 more
wiley +1 more source
Taxanes are widely used chemotherapeutics whose effects on cellular mechanics remain poorly understood. We show that paclitaxel induces rapid cellular contraction by promoting GEF‐H1 dissociation from microtubules and non‐muscle myosin II activation through RhoA/ROCK.
Gloria Asensio‐Juárez +5 more
wiley +1 more source
The Complement fixation test [PDF]
The use of the complement fixation reaction in the diagnosis of disease was first introduced by Bordet and Gengou in 1901. With serum s from individuals suspected of having typhoid fever, combined with typhoid antigens, they were able to demonstrate ...
core
Complement in HER2-Positive Breast Cancer: A Conditionally Protective Mechanism Under Attack. [PDF]
Petkova D +6 more
europepmc +1 more source
We established the avian chorioallantoic membrane (CAM) assay as a scalable in vivo model for studying circulating tumor cells (CTCs). Human gastrointestinal tumors spontaneously released genetically validated CTCs that were detected across multiple platforms, demonstrating that the CAM model provides an accessible tool for investigating early cancer ...
Dennis Roth +17 more
wiley +1 more source
Complement Signaling and Regulated Cell Death in Immune-Mediated Glomerular Injury. [PDF]
Tzali E +3 more
europepmc +1 more source

